Among NAW, the APC I1307K rate was higher among melanoma patients in both sexes [OR 2.54 (95% CI 1.57–3.98), p < 0.01 (Figure 3)], as well as in breast (female only) and prostate (male only) cancer patients [OR 1.73 (95% CI 1.18–2.65), p < 0.01; OR 2.42 (95% CI 1.45–3.94), p < 0.01, respectively (Figure 3)]. Here, APC is linked to melanoma.